Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in France
Date:7/7/2009

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership in France through Medipartner, a Paris based firm specializing in the marketing and distribution of innovative gastrointestinal medical devices. The Company believes that building an effective distribution network in France will also enhance sales in the emerging North African and Middle Eastern markets due to their relationship with France.

Michel Vaudry, SpectraScience's VP of Sales and Marketing, said, "We are pleased to add Medipartner to our expanding distribution footprint throughout Europe, and are optimistic that physicians and more importantly, patients in France will greatly benefit from the introduction of WavSTAT to this market. In terms of cancers plaguing France's population, colon cancer has one of the highest rates of incidence and mortality."

Medipartner's Chief Executive, Christian Arnould, stated that, "We decided to add the WavSTAT to products that we distribute because it is both innovative and it will translate into progress for cancer detection. Our focus is in the gastrointestinal market, and based on our experience and understanding of that market, I think that the WavSTAT is a great fit for us, and our customers." Medipartner is the French distributor for Sandhill Scientific, a leading international GI diagnostics company based in Colorado.

"We are shipping a unit to France this week," added Vaudry. "I will be going to France to assist Christian in making demonstrations of the WavSTAT to physicians at several healthcare centers of excellence, including the Hospital Edourard Herriot in Lyon, which has just been ranked as one of the 10 best healthcare centers in the world by Newsweek magazine." In addition, Mr. Vaudry noted that Lyon is the headquarters of the International Agency for Research on Cancer (IARC), one of the most prestigious cancer research facilities in operation today.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. In addition, the Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today.

    Contact:

    SpectraScience, Inc.                         Hayden
    Communications                               Investor Relations

    Jim Hitchin, Chief Executive Officer         Todd Pitcher
    (858) 847-0200 x 201                         (858)-518-1387

   http://www.spectrascience.com


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Spain
2. SpectraScience Receives FDA Clearance for Manufacturing Facility
3. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
4. SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement
5. SpectraScience Announces Business Update
6. SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus
7. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
8. SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis
9. SpectraScience Announces Updates
10. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
11. SpectraScience Awarded Patent for Correcting Image Misalignment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: